نتایج جستجو برای: ژن fgfr2

تعداد نتایج: 17039  

Journal: :Molecular and cellular biology 2007
Imad Shams Edyta Rohmann Veraragavan P Eswarakumar Erin D Lew Satoru Yuzawa Bernd Wollnik Joseph Schlessinger Irit Lax

Lacrimo-auriculo-dento-digital (LADD) syndrome is characterized by abnormalities in lacrimal and salivary glands, in teeth, and in the distal limbs. Genetic studies have implicated heterozygous mutations in fibroblast growth factor 10 (FGF10) and in FGF receptor 2 (FGFR2) in LADD syndrome. However, it is not clear whether LADD syndrome mutations (LADD mutations) are gain- or loss-of-function mu...

Journal: :Cancer research 1998
A Matsubara M Kan S Feng W L McKeehan

A loss of expression of fibroblast growth factor (FGF) receptor 2 IIIb (FGFR2IIIb), which responds to stroma-derived FGF, accompanies progression of premalignant androgen-responsive rat prostate tumor epithelial cells to the malignant phenotype. Concurrently, the level of FGFR2 gene expression is reduced and lost altogether in over 30% of cells, whereas all malignant cells abnormally express FG...

Journal: :Development 2005
Anita Petiot Claire L Perriton Clive Dickson Martin J Cohn

Development of external genitalia in mammalian embryos requires tight coordination of a complex series of morphogenetic events involving outgrowth, proximodistal and dorsoventral patterning, and epithelial tubulogenesis. Hypospadias is a congenital defect of the external genitalia that results from failure of urethral tube closure. Although this is the second most common birth defect in humans,...

2011
Neus Martínez-Abadías Yann Heuzé Yingli Wang Ethylin Wang Jabs Kristina Aldridge Joan T. Richtsmeier

The fibroblast growth factor and receptor system (FGF/FGFR) mediates cell communication and pattern formation in many tissue types (e.g., osseous, nervous, vascular). In those craniosynostosis syndromes caused by FGFR1-3 mutations, alteration of signaling in the FGF/FGFR system leads to dysmorphology of the skull, brain and limbs, among other organs. Since this molecular pathway is widely expre...

2017
Ying Lin Hongbin Gao Siming Ai Jacob V.P. Eswarakumar Chuan Chen Yi Zhu Tao Li Bingqian Liu Xialin Liu Lixia Luo Hongye Jiang Yonghao Li Xiaoling Liang Chenjin Jin Xinhua Huang Lin Lu

The current study was performed with aim to investigate the fibroblast growth factor receptor 2 (FGFR2) gene in two Chinese families with two different forms of syndromic craniosynostosis, and to characterize their associated clinical features. Two families underwent complete ophthalmic examinations, and two patients from each family were diagnosed with craniosynostosis. Genomic DNA was extract...

2017
YING LIN HONGBIN GAO CHUAN CHEN YI ZHU TAO LI BINGQIAN LIU XIALIN LIU LIXIA LUO HONGYE JIANG YONGHAO LI XIAOLING LIANG CHENJIN JIN XINHUA HUANG

The current study was performed with aim to investigate the fibroblast growth factor receptor 2 (FGFR2) gene in two Chinese families with two different forms of syndromic craniosynostosis, and to characterize their asso‐ ciated clinical features. Two families underwent complete ophthalmic examinations, and two patients from each family were diagnosed with craniosynostosis. Genomic DNA was extra...

Journal: :Cancer discovery 2017
Lipika Goyal Supriya K Saha Leah Y Liu Giulia Siravegna Ignaty Leshchiner Leanne G Ahronian Jochen K Lennerz Phuong Vu Vikram Deshpande Avinash Kambadakone Benedetta Mussolin Stephanie Reyes Laura Henderson Jiaoyuan Elisabeth Sun Emily E Van Seventer Joseph M Gurski Sabrina Baltschukat Barbara Schacher-Engstler Louise Barys Christelle Stamm Pascal Furet David P Ryan James R Stone A John Iafrate Gad Getz Diana Graus Porta Ralph Tiedt Alberto Bardelli Dejan Juric Ryan B Corcoran Nabeel Bardeesy Andrew X Zhu

Genetic alterations in the fibroblast growth factor receptor (FGFR) pathway are promising therapeutic targets in many cancers, including intrahepatic cholangiocarcinoma (ICC). The FGFR inhibitor BGJ398 displayed encouraging efficacy in patients with FGFR2 fusion-positive ICC in a phase II trial, but the durability of response was limited in some patients. Here, we report the molecular basis for...

2014
Yoshito Nakanishi Nukinori Akiyama Toshiyuki Tsukaguchi Toshihiko Fujii Kiyoaki Sakata Hitoshi Sase Takehito Isobe Kenji Morikami Hidetoshi Shindoh Toshiyuki Mio Hirosato Ebiike Naoki Taka Yuko Aoki Nobuya Ishii

The FGF receptors (FGFR) are tyrosine kinases that are constitutively activated in a subset of tumors by genetic alterations such as gene amplifications, point mutations, or chromosomal translocations/rearrangements. Recently, small-molecule inhibitors that can inhibit the FGFR family as well as the VEGF receptor (VEGFR) or platelet-derived growth factor receptor (PDGFR) family displayed clinic...

Journal: :PLoS Biology 2008
Kerstin B Meyer Ana-Teresa Maia Martin O'Reilly Andrew E Teschendorff Suet-Feung Chin Carlos Caldas Bruce A. J Ponder

The recent whole-genome scan for breast cancer has revealed the FGFR2 (fibroblast growth factor receptor 2) gene as a locus associated with a small, but highly significant, increase in the risk of developing breast cancer. Using fine-scale genetic mapping of the region, it has been possible to narrow the causative locus to a haplotype of eight strongly linked single nucleotide polymorphisms (SN...

2013
Hae Jeong Park Su Kang Kim Jong Woo Kim Sang Hyub Lee Koo Han Yoo Joo-Ho Chung

Fibroblast growth factors (FGFs) and their receptors (FGFRs) have been implicated in prostate growth and are overexpressed in benign prostatic hyperplasia (BPH). In this study, we investigated whether single nucleotide polymorphisms (SNPs) of the FGFR genes (FGFR1 and FGFR2) were associated with BPH and its clinical phenotypes in a population of Korean men. We genotyped four SNPs in the exons o...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید